Akamai Technologies enters the final week of September with a sharp divergence at its core: short sellers have been covering steadily for a month while the Street, in a burst of activity on September 25, raised price targets across the board — yet the stock at $113.94 still trades a full 28% below the analyst consensus target of $158.79.
The short-covering story has been the dominant market dynamic for AKAM over the past five weeks. Short interest has fallen from roughly 20.6 million shares in mid-August to 17.7 million now — a 14% decline in a month — and 5.7% in just the past week. At 12.3% of the free float, shorts remain meaningfully elevated, but the direction is unambiguous: bears have been reducing exposure into the stock's rally. The borrow market reflects that change. Availability has loosened sharply, jumping 46% week-on-week to 462% — meaning there are now more than four shares available to borrow for every one currently on loan, the most room in the lending pool all year. Cost to borrow remains near-trivial at 0.55%, barely moved over the month. The ORTEX short score has also drifted lower all week, from 63.3 on September 15 to 58.9 by September 24 — scoring in only the 14th percentile for short pressure among peers. None of this signals squeeze risk; it signals an orderly exit.
Options traders are leaning the same direction. The put/call ratio at 0.26 is near its 52-week low of 0.23, and slightly below its 20-day average of 0.27 — call activity dominates, and the skew has barely budged even as the stock climbed 9% on the week. There is no hedging surge ahead of the November 3 earnings date. That is notable because the last print, in August, delivered a punishing 9.6% single-day drop before recovering 2.5% over the following five days.
The clearest catalyst for this week's tone was a coordinated burst of analyst activity on September 25. Multiple firms raised targets on the same day. Guggenheim lifted to $225 from $190, maintaining Buy. BofA Securities raised to $185 from $175, also Buy. JP Morgan moved to $167 from $158, staying Neutral. Piper Sandler lifted aggressively to $158 from $125, reiterating Overweight. UBS and TD Cowen each raised targets while keeping neutral-leaning ratings. The consensus tells a mixed story: nine Hold ratings against five Outperform-equivalent, with the Hold camp clustered around $135-$167 and the Bulls anchored at $185-$225. The forward earnings picture adds texture — the 12-month forward EPS growth estimate ranks in the 97th percentile, suggesting analysts see a significant earnings inflection ahead. That sits in contrast to weaker near-term EPS momentum scores (39th and 35th percentile on 30- and 90-day revisions), which points to a story that is more about future expectations than current execution.
The bull case rests on Akamai's pivot from legacy content delivery toward security and cloud computing, where revenue has already overtaken the CDN business. The bear case — articulated by the Hold-heavy analyst camp — focuses on margin pressure during the investment cycle, crowded competition in cloud and security, and hardware-as-a-service cost headwinds. Citigroup, notably, cut its target to $122 from $160 as recently as September 4, before this week's broad upward revision wave. That gap — a single neutral firm at $122 while a Bull sits at $225 — captures the spread of conviction on the stock.
On the ownership side, Capital Research and Management Company is now the largest disclosed holder at 7.9% of shares, having added 4.5 million shares as of August 31. BlackRock added 1.35 million shares in the same period. Neither has filed a Schedule 13D, and no activist is on the register. The Vanguard Group's 13G/A shows a peculiar picture — its aggregate entity filing lists 0% ownership as of March 2026, while two separate Vanguard sub-entities filed fresh 13Gs in April showing a combined 12.5%. Stakes are as-last-disclosed around the 5% threshold, and positions can shift materially before a new filing is required.
With earnings six weeks out on November 3, the November print is the next real test of whether the Street's target upgrades are getting ahead of the fundamental story — or whether the covering shorts were simply the first to price in a better quarter.
See the live data behind this article on ORTEX.
Open AKAM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
